文献速递临床试验与 GCP

个体化针刺、固定针刺、来曲唑与安慰剂来曲唑对多囊卵巢综合征不孕女性活产影响的多中心随机试验

A multicenter randomized trial of personalized acupuncture, fixed acupuncture, letrozole, and placebo letrozole on live birth in infertile women with polycystic ovary syndrome.
PubMed 文献 · Trials · 2020-03-04

本研究为评估者盲法多中心随机对照试验,计划纳入1100例多囊卵巢综合征不孕女性,随机分为个体化针刺、固定针刺、来曲唑或安慰剂来曲唑四组,治疗16周,主要结局为活产。研究旨在比较个体化或固定针刺与来曲唑或安慰剂来曲唑对活产率的影响,并假设来曲唑优于个体化针刺,个体化针刺优于固定针刺,安慰剂来曲唑效果最差。

要点

  • 首个比较个体化/固定针刺与来曲唑/安慰剂来曲唑对PCOS不孕女性活产影响的多中心RCT。
  • 个体化针刺可能降低流产率和妊娠并发症风险(研究假设)。
  • 主要结局为活产,次要结局包括排卵率、受孕率、妊娠率等。

核心结论

  • 研究将首次通过多中心RCT比较个体化或固定针刺与来曲唑或安慰剂来曲唑对PCOS不孕女性活产的影响。
  • 研究假设来曲唑优于个体化针刺,个体化针刺优于固定针刺,安慰剂来曲唑效果最差。
  • 研究假设个体化针刺较来曲唑更可能降低流产率和妊娠并发症风险。

研究设计与样本

  • 评估者盲法多中心随机对照试验,计划从28家医院招募1100例多囊卵巢综合征不孕女性。
  • 随机分为个体化针刺、固定针刺、来曲唑、安慰剂来曲唑四组,治疗16周。
  • 主要结局为活产,次要结局包括排卵率、受孕率、妊娠率、妊娠丢失率、激素和代谢参数变化及生活质量评分变化。

关键数值与推荐

  • 主要结局为活产。
  • 次要结局包括排卵率、受孕率、妊娠率、妊娠丢失率、激素和代谢参数变化、生活质量评分变化。
  • 治疗周期为16周。
  • 统计学显著性水平为P值<0.05。

临床怎么用

  • 研究结果将提示个体化针刺疗法是否可作为改善PCOS不孕女性活产率的替代治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Traditional Chinese medicine (TCM) usually involves syndrome differentiation and treatment. Acupuncture, one form of TCM, requires the selection of appropriate acupoints and needling techniques, but many clinical trials on acupuncture have used fixed acupuncture protocols without accounting for individual patient differences. We have designed a multicenter randomized controlled trial (RCT) to evaluate whether personalized or fixed acupuncture increases the likelihood of live births in infertile women with polycystic ovary syndrome (PCOS) compared with letrozole or placebo letrozole. We hypothesize that letrozole is more effective than personalized acupuncture, which in turn is more effective than fixed acupuncture, and that placebo letrozole is the least effective intervention. Moreover, we hypothesize that personalized acupuncture is more likely to reduce the miscarriage rate and the risk of pregnancy complications compared with letrozole. METHODS/DESIGN: The study is designed as an assessor-blinded RCT. A total of 1100 infertile women with PCOS will be recruited from 28 hospitals and randomly allocated to 4 groups: personalized acupuncture, fixed acupuncture, letrozole, or placebo letrozole. They will receive treatment for 16 weeks, and the primary outcome is live birth. Secondary outcomes include ovulation rate, conception rate, pregnancy rate, pregnancy loss rate, changes in hormonal and metabolic parameters, and changes in quality of life scores. Adverse events will be recorded throughout the trial. All statistical analyses will be performed using IBM SPSS Statistics version 21.0 software (IBM Corp., Armonk, NY, USA), and a P value < 0.05 will be considered statistically significant. DISCUSSION: This study will be the first multicenter RCT to compare the effect of personalized or fixed acupuncture with letrozole or placebo letrozole on live birth in infertile women with PCOS. The findings will inform whether personalized acupuncture therapy can be considered an alternative treatment to improve the live birth rate in infertile women with PCOS. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03625531. Registered on July 13, 2018. Chinese Clinical Trial Registry, ChiCTR1800017304. Registered on July 23, 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Huang S, Hu M, Ng EHY, et al. A multicenter randomized trial of personalized acupuncture, fixed acupuncture, letrozole, and placebo letrozole on live birth in infertile women with polycystic ovary syndrome. Trials. 2020. PMID: 32131886. doi:10.1186/s13063-020-4154-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。